I posted recently about a large study where higher FT4, but no other tests such as TSH and FT3, had an influence on atrial fibrillation likelihood. We've now had a paper on the same lines and with basically the same conclusion accepted by Frontiers in Thyroid Endocrinology:
Front. Endocrinol. | doi: 10.3389/fendo.2020.542710
The two faces of Janus: Why thyrotropin as a cardiovascular risk factor may be an ambiguous target
At the moment it is only in preliminary (title) form. It criticises another study which concluded that it was TSH that was the link rather than FT4. Reanalysing their data, it again seems that this isn't so, and high FT4 is truly the link to cardiovascular problems (small as they may be).